De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review.
作者信息
Guo Hanxu, Jin Chengqi, Ding Li, Xie Jun, Xu Jing, Wang Ruiliang, Wang Hong, Guo Changcheng, Zhang Jiansheng, Peng Bo, Yao Xudong, Yuan Jing, Yang Bin
机构信息
Department of Urology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Department of Urology, Urologic Cancer Institute, Tongji University School of Medicine, Shanghai 200072, China.
出版信息
Chin Med J (Engl). 2025 Jan 20;138(2):231-233. doi: 10.1097/CM9.0000000000003311. Epub 2024 Sep 27.
Abstract
摘要
Zotero 插件